manufacturing method for production and purification of raav vectors (Applied Genetic Technologies Corporation)
90
Structured Review
Applied Genetic Technologies Corporation
manufacturing method for production and purification of raav vectors
Manufacturing Method For Production And Purification Of Raav Vectors, supplied by Applied Genetic Technologies Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manufacturing+method+for+production+and+purification+of+raav+vectors/manufacturing+method+for+production+and+purification+of+raav+vectors/10__1089_slash_hum__2014__060-31-15-0
Average 90 stars, based on 1 article reviews
Manufacturing Method For Production And Purification Of Raav Vectors, supplied by Applied Genetic Technologies Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/manufacturing+method+for+production+and+purification+of+raav+vectors/manufacturing+method+for+production+and+purification+of+raav+vectors/10__1089_slash_hum__2014__060-31-15-0
Average 90 stars, based on 1 article reviews
manufacturing method for production and purification of raav vectors - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Purification:Article Title: Herpes Simplex Virus Clearance during Purification of a Recombinant Adeno-associated Virus Serotype 1 Vector Article Snippet: Gene delivery vectors based on adeno-associated virus (AAV) have potential utility for treatment of many genetic disorders.. Current AAV vector manufacturing methods employ helper viruses to deliver functions needed to produce replication-defective recombinant AAV (rAAV) vectors, and clearance of infectious helper virus from the drug substance is essential for ensuring the safety of rAAV-based therapies.. We have developed a manufacturing method for the production of rAAV vectors using a recombinant herpes simplex virus type 1 (rHSV) complementation system in suspension baby hamster kidney (sBHK) cells. Recombinant:Article Title: Herpes Simplex Virus Clearance during Purification of a Recombinant Adeno-associated Virus Serotype 1 Vector Article Snippet: Gene delivery vectors based on adeno-associated virus (AAV) have potential utility for treatment of many genetic disorders.. Current AAV vector manufacturing methods employ helper viruses to deliver functions needed to produce replication-defective recombinant AAV (rAAV) vectors, and clearance of infectious helper virus from the drug substance is essential for ensuring the safety of rAAV-based therapies.. We have developed a manufacturing method for the production of rAAV vectors using a recombinant herpes simplex virus type 1 (rHSV) complementation system in suspension baby hamster kidney (sBHK) cells. Virus:Article Title: Herpes Simplex Virus Clearance during Purification of a Recombinant Adeno-associated Virus Serotype 1 Vector Article Snippet: Gene delivery vectors based on adeno-associated virus (AAV) have potential utility for treatment of many genetic disorders.. Current AAV vector manufacturing methods employ helper viruses to deliver functions needed to produce replication-defective recombinant AAV (rAAV) vectors, and clearance of infectious helper virus from the drug substance is essential for ensuring the safety of rAAV-based therapies.. We have developed a manufacturing method for the production of rAAV vectors using a recombinant herpes simplex virus type 1 (rHSV) complementation system in suspension baby hamster kidney (sBHK) cells. Suspension:Article Title: Herpes Simplex Virus Clearance during Purification of a Recombinant Adeno-associated Virus Serotype 1 Vector Article Snippet: Gene delivery vectors based on adeno-associated virus (AAV) have potential utility for treatment of many genetic disorders.. Current AAV vector manufacturing methods employ helper viruses to deliver functions needed to produce replication-defective recombinant AAV (rAAV) vectors, and clearance of infectious helper virus from the drug substance is essential for ensuring the safety of rAAV-based therapies.. We have developed a manufacturing method for the production of rAAV vectors using a recombinant herpes simplex virus type 1 (rHSV) complementation system in suspension baby hamster kidney (sBHK) cells. |